ETFs are MIA; answering some reader requests.
Gottlieb is the preferred FDA Commissioner pick of the drug industry and healthcare investors.
The Republican-led House of Representatives has rolled out a new health insurance bill. How will it affect health care sector companies' bottom lines?
The firms all have drugs they want the feds to bend the rules to approve.